Skip to main content
Premium Trial:

Request an Annual Quote

New Products: CTGT's Connective Tissue Gene Tests

Premium

Connective Tissue Gene Tests (CTGT) has added 12 new assays to its menu of molecular diagnostics for inherited disorders affecting connective tissues.

The Allentown, Pa.-based company is now offering microarray, Sanger sequencing, and next-generation sequencing-based tests for genes associated with Adams-Oliver syndrome, cerebral cavernous malformations, cutis laxa, multiple self-healing squamous epithelioma, opsismodysplasia, and supervalvular aortic stenosis.

The pricing of CTGT's new tests depends on the technology used and the number of genes assessed. For its array-based tests, the company relies on its High-Density Targeted Array platform, an Agilent Technologies-manufactured chip for copy number variation detection.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.